Across TCGA pan-cancer cohorts, MIR501 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR501 data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR501 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR501 expression acts as an unfavorable survival marker.
ACC, KIRP, and GBM are the cancer types where MIR501 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.